Organism name | Papaver orientale |
---|---|
Genus | Papaver |
Family | Papaveraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Papaver orientale |
---|---|
Linked NCBI taxonomy ID | 22694 |
Linked level | species |
Family in NCBI taxonomy | Papaveraceae |
---|---|
ID | 3465 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005539
![]() |
Isorhamnetin 3-vicianoside
|
No. 1 | No. 15 |
![]() |
||||
C00006636
![]() |
Pelargonidin 3-sophoroside
|
No. 1 | No. 15 |
![]() |
||||
C00006649
![]() |
Pelargonidin 3-sophoroside-7-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00001823
![]() |
Bracteoline
|
CHEMBL410604
CHEMBL1316470 |
C002507
|
13 / 18 / 47 | No. 20 | No. 4 |
![]() |
|
C00027305
![]() |
Bracteoline
|
CHEMBL410604
CHEMBL1316470 |
C002507
|
13 / 18 / 47 | No. 20 | No. 4 |
![]() |
|
C00001873
![]() |
Isothebaine
|
C111588
|
No. 20 | No. 4 |
![]() |
|||
C00001869
![]() |
Isoboldine
/ (S)-Isoboldine |
CHEMBL462880
|
19 / 22 / 55 | No. 20 | No. 4 |
![]() |
||
C00026092
![]() |
Scoulerine
/ (-)-Scoulerine |
CHEMBL191133
CHEMBL1235966 CHEMBL1395394 |
27 / 19 / 15 | No. 37 | No. 4 |
![]() |
||
C00024668
![]() |
YHL II
/ Coptisine |
CHEMBL362071
|
C034384
|
No. 155 | No. 4 |
![]() |
||
C00027159
![]() |
Depiline
/ Palmatine / Berbericinine / O,O-Dimethyldemethyleneberberine |
CHEMBL206106
|
C005413
|
8 / 13 / 13 | 8 / 0 | No. 155 | No. 4 |
![]() |
C00026109
![]() |
Alborine
|
No. 155 | No. 4 |
![]() |
||||
C00001885
![]() |
Escholin
/ Escholine / Thalictrin / Thalictrine / Magnoflorine / (+)-Magnoflorine |
CHEMBL235428
|
C001670
|
No. 286 | No. 4 |
![]() |
||
C00025463
![]() |
Papaverrubine G
|
No. 305 |
![]() |
|||||
C00025457
![]() |
Papaverrubin A
/ Papaverrubine A / N-Demethylisorheadine |
No. 305 |
![]() |
|||||
C00001916
![]() |
Salutaridine
/ (+)-Salutaridine |
CHEMBL402782
CHEMBL404097 |
C009270
|
3 / 4 / 2 | No. 426 | No. 4 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001823 C00001869 C00026092 C00027159 C00027305 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001823 C00001869 C00026092 C00027159 C00027305 | 0 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001823 C00001869 C00026092 C00027159 C00027305 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001823 C00001869 C00026092 C00027159 C00027305 | 1 / 1 |
P29466 | Caspase-1 | C14 | C00001823 C00001869 C00026092 C00027305 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001823 C00001869 C00026092 C00027305 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001823 C00001869 C00027305 | 4 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001823 C00001869 C00027305 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001823 C00001869 C00027305 | 7 / 37 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001823 C00001869 C00027305 | 3 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001823 C00001869 C00027305 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001823 C00001869 C00027305 | 2 / 2 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001823 C00027305 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00026092 C00027159 | 11 / 10 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00026092 C00027159 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00026092 C00027159 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00026092 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00026092 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00026092 | 1 / 1 |
P00734 | Prothrombin | S1A | C00001916 | 4 / 2 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00026092 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00027159 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00026092 | 2 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00026092 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00026092 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001916 | 0 / 0 |
P55210 | Caspase-7 | C14 | C00001869 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001916 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00026092 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00026092 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001869 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00026092 | 0 / 0 |
O14727 | Apoptotic protease-activating factor 1 | Unclassified protein | C00026092 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00026092 | 0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00026092 | 1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00026092 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00026092 | 1 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001869 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00026092 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00026092 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00026092 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00001869 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001869 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001869 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001869 | 1 / 4 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00027159
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00027159
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00027159
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00027159
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00027159
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00027159
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00027159
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00027159
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P14416
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|